{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T04:10:47Z","timestamp":1775275847572,"version":"3.50.1"},"reference-count":16,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T00:00:00Z","timestamp":1739923200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Erasmus MC Efficiency","award":["2020-20107"],"award-info":[{"award-number":["2020-20107"]}]},{"name":"Erasmus MC University Medical Centre"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>A drawback of vancomycin use is the need for therapeutic drug monitoring and renal function monitoring. Traditional blood sampling involves drawing blood through a venepuncture. An alternative method, dried blood spot (DBS) sampling allows for self-sampling at home.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To clinically validate a DBS method for simultaneous monitoring of vancomycin and creatinine.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Hospitalized adults treated with intravenous vancomycin were included (trial registration NCT05257070). Blood sampling consisted of one venepuncture and one finger prick. Whole-blood DBS samples from patients were obtained by applying one drop of whole blood onto Whatman 903 filtrate paper. Bland\u2013Altman analyses were used to assess the agreement and bias between the two measurements. Patients were asked to state their preferences for one of the two sampling methods.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The study involved a final analysis of 39 patient samples for the clinical validation of vancomycin and 46 patient samples for the clinical validation of creatinine. The difference between plasma and DBS concentrations was \u226420% for 77% of the vancomycin samples, the mean bias was \u22120.1379% (95% limit of agreement \u22125.899\u20135.623). The difference between plasma and DBS concentrations was \u226420% for 89% of the creatinine samples, the mean bias was 2.656% (95% limit of agreement \u221226.16\u201331.47). Most patients (18 out of 31) preferred a finger prick over a venepuncture and 12 patients indicated no preference.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>This is the first study that successfully clinically validated a DBS sampling method for simultaneous measurement of vancomycin and creatinine, allowing for direct use in (outpatient) practice.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jac\/dkaf041","type":"journal-article","created":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T12:20:56Z","timestamp":1738326056000},"page":"1097-1107","source":"Crossref","is-referenced-by-count":2,"title":["Clinical validation of an innovative dried whole-blood spot method to quantify simultaneously vancomycin and creatinine in adult patients"],"prefix":"10.1093","volume":"80","author":[{"given":"M","family":"Hassanzai","sequence":"first","affiliation":[{"name":"Department of Hospital Pharmacy, Erasmus MC University Medical Centre , Rotterdam ,","place":["The Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Bahmany","sequence":"additional","affiliation":[{"name":"Department of Hospital Pharmacy, Erasmus MC University Medical Centre , Rotterdam ,","place":["The Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H A W","family":"van Onzenoort","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Radboud University Medical Centre, Radboud Institute for Health Sciences , Nijmegen ,","place":["The Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"van Oldenrijk","sequence":"additional","affiliation":[{"name":"Department of Orthopaedics and Sports Medicine, Erasmus MC University Medical Center , Rotterdam ,","place":["The Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1202-3643","authenticated-orcid":false,"given":"B C P","family":"Koch","sequence":"additional","affiliation":[{"name":"Department of Hospital Pharmacy, Erasmus MC University Medical Centre , Rotterdam ,","place":["The Netherlands"]},{"name":"Department of Hospital Pharmacy and Medical Microbiology, CATOR: Centre for Antimicrobial Treatment Optimization Rotterdam , Rotterdam ,","place":["The Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B C M","family":"de Winter","sequence":"additional","affiliation":[{"name":"Department of Hospital Pharmacy, Erasmus MC University Medical Centre , Rotterdam ,","place":["The Netherlands"]},{"name":"Department of Hospital Pharmacy and Medical Microbiology, CATOR: Centre for Antimicrobial Treatment Optimization Rotterdam , Rotterdam ,","place":["The Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,2,19]]},"reference":[{"key":"2025040208391470500_dkaf041-B1","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1097\/FTD.0000000000000944","article-title":"Optimal practice for vancomycin therapeutic drug monitoring: position statement from the anti-infectives committee of the international association of therapeutic drug monitoring and clinical toxicology","volume":"44","author":"Reuter","year":"2022","journal-title":"Ther Drug Monit"},{"key":"2025040208391470500_dkaf041-B2","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1592\/phco.29.11.1275","article-title":"Therapeutic monitoring of vancomycin in adults: summary of consensus recommendations from the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists","volume":"29","author":"Rybak","year":"2009","journal-title":"Pharmacotherapy"},{"key":"2025040208391470500_dkaf041-B3","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s10156-013-0599-4","article-title":"Practice guidelines for therapeutic drug monitoring of vancomycin: a consensus review of the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring","volume":"19","author":"Matsumoto","year":"2013","journal-title":"J Infect Chemother"},{"key":"2025040208391470500_dkaf041-B4","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/ciy867","article-title":"2018 Infectious Diseases Society of America clinical practice guideline for the management of outpatient parenteral antimicrobial therapy","volume":"68","author":"Norris","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2025040208391470500_dkaf041-B5","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1093\/jpids\/piaa057","article-title":"Executive summary: therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: a revised consensus guideline and review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists","volume":"9","author":"Rybak","year":"2020","journal-title":"J Pediatric Infect Dis Soc"},{"key":"2025040208391470500_dkaf041-B6","doi-asserted-by":"publisher","first-page":"dlaa113","DOI":"10.1093\/jacamr\/dlaa113","article-title":"Evaluating the safety and effectiveness of a nurse-led outpatient virtual IV vancomycin monitoring clinic: a retrospective cohort study","volume":"3","author":"Grattan","year":"2021","journal-title":"JAC Antimicrob Resist"},{"key":"2025040208391470500_dkaf041-B7","doi-asserted-by":"publisher","first-page":"256","DOI":"10.4269\/ajtmh.17-0889","article-title":"Dried blood spots for global health diagnostics and surveillance: opportunities and challenges","volume":"99","author":"Lim","year":"2018","journal-title":"Am J Trop Med Hyg"},{"key":"2025040208391470500_dkaf041-B8","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1111\/bcp.13755","article-title":"Therapeutic drug monitoring of tacrolimus and mycophenolic acid in outpatient renal transplant recipients using a volumetric dried blood spot sampling device","volume":"84","author":"Zwart","year":"2018","journal-title":"Br J Clin Pharmacol"},{"key":"2025040208391470500_dkaf041-B9","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jchromb.2013.02.035","article-title":"Analysis of tacrolimus and creatinine from a single dried blood spot using liquid chromatography tandem mass spectrometry","volume":"926","author":"Koop","year":"2013","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"2025040208391470500_dkaf041-B10","doi-asserted-by":"publisher","first-page":"117689","DOI":"10.1016\/j.cca.2023.117689","article-title":"Dried blood spot analysis for the quantification of vancomycin and creatinine using liquid chromatography\u2014tandem mass spectrometry: method development and validation","volume":"553","author":"Bahmany","year":"2024","journal-title":"Clin Chim Acta"},{"key":"2025040208391470500_dkaf041-B11","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1097\/FTD.0000000000000643","article-title":"Official international association for therapeutic drug monitoring and clinical toxicology guideline: development and validation of dried blood spot-based methods for therapeutic drug monitoring","volume":"41","author":"Capiau","year":"2019","journal-title":"Ther Drug Monit"},{"key":"2025040208391470500_dkaf041-B12","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1097\/FTD.0000000000000834","article-title":"Development and validation of hematocrit level measurement in dried blood spots using near-infrared spectroscopy","volume":"43","author":"van de Velde","year":"2021","journal-title":"Ther Drug Monit"},{"key":"2025040208391470500_dkaf041-B13","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.cca.2021.10.002","article-title":"Near-infrared-based hematocrit prediction of dried blood spots: an in-depth evaluation","volume":"523","author":"Delahaye","year":"2021","journal-title":"Clin Chim Acta"},{"key":"2025040208391470500_dkaf041-B14","doi-asserted-by":"publisher","first-page":"e5586","DOI":"10.1002\/bmc.5586","article-title":"Development and validation of a dried plasma spot LC-MS\/MS method for therapeutic monitoring of vancomycin and comparison with enzyme-multiplied immunoassay","volume":"37","author":"Vidal","year":"2023","journal-title":"Biomed Chromatogr"},{"key":"2025040208391470500_dkaf041-B15","doi-asserted-by":"publisher","first-page":"1055200","DOI":"10.3389\/fped.2022.1055200","article-title":"Applicability of vancomycin, meropenem, and linezolid in capillary microsamples vs. dried blood spots: a pilot study for microsampling in critically ill children","volume":"10","author":"Xiaoyong","year":"2023","journal-title":"Front Pediatr"},{"key":"2025040208391470500_dkaf041-B16","doi-asserted-by":"publisher","first-page":"121897","DOI":"10.1016\/j.jchromb.2019.121897","article-title":"Vancomycin and creatinine determination in dried blood spots: analytical validation and clinical assessment","volume":"1137","author":"Scribel","year":"2020","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/80\/4\/1097\/61976508\/dkaf041.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/80\/4\/1097\/61976508\/dkaf041.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T09:28:02Z","timestamp":1743586082000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/80\/4\/1097\/8023878"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,19]]},"references-count":16,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,2,19]]},"published-print":{"date-parts":[[2025,4,2]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkaf041","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,4]]},"published":{"date-parts":[[2025,2,19]]}}}